| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/02/2009 | US20090169598 Treatment of bacterial infections |
| 07/02/2009 | US20090169597 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells |
| 07/02/2009 | US20090169595 Controlled Release Polymeric Compositions of Bone Growth Promoting Compounds |
| 07/02/2009 | US20090169592 Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
| 07/02/2009 | US20090169591 Medical articles for the treatment of tumors |
| 07/02/2009 | US20090169588 Compositions Containing Proteins for the Transfer/Recycling of Structurally Modified Lipids, and the Applications Thereof |
| 07/02/2009 | US20090169587 Chronotherapeutic dosage forms |
| 07/02/2009 | US20090169586 Stable packaged dosage form and process therefor |
| 07/02/2009 | US20090169585 Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | US20090169583 Solid Adsorbates of Hydrophobic Drugs |
| 07/02/2009 | US20090169574 Heteroclitic analogs and related methods |
| 07/02/2009 | US20090169559 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 07/02/2009 | US20090169490 Composition and method for weight loss |
| 07/02/2009 | US20090169488 Acidic solid oral compositons without erosive potential in saliva and method for determining erosive potential in saliva |
| 07/02/2009 | US20090169487 Essential Oil Diffusion |
| 07/02/2009 | US20090169486 Biomedical foam articles |
| 07/02/2009 | US20090169485 Gene therapy and pharmaceutical composition for prevention and treatment of lung cancer |
| 07/02/2009 | US20090169478 In Vivo Imaging and Therapy with Magnetic Nanoparticle Conjugates |
| 07/02/2009 | US20090169472 Methods and compositions for treating immune disorders |
| 07/02/2009 | US20090169471 Particles for injection and processes for forming the same |
| 07/02/2009 | US20090166903 Molded waveguides |
| 07/02/2009 | DE202008016055U1 Kosmetische oder medizinische Zubereitung enthaltend Biotin Cosmetic or medicinal preparation containing biotin |
| 07/02/2009 | DE102007063395A1 Transport-, Weitergabe- und/oder Wirksystem in aseptischer Darreichung Transportation, Weitergabe- and / or active system in aseptic administration |
| 07/02/2009 | CA2738403A1 Domestic animal parasite-repellent device |
| 07/02/2009 | CA2712414A1 Pharmaceutical composition |
| 07/02/2009 | CA2710646A1 Medicament for the treatment of cancer of the pancreas |
| 07/02/2009 | CA2710605A1 Anti - retroviral combination |
| 07/02/2009 | CA2710600A1 Recombinant rsv antigens |
| 07/02/2009 | CA2710490A1 Drug delivery system |
| 07/02/2009 | CA2710338A1 Resuscitation fluid |
| 07/02/2009 | CA2710125A1 Active pharmaceutical ingredient on a solid support, amorphous and with an improved solubility |
| 07/02/2009 | CA2710062A1 Solid lipid microcapsules containing growth hormone in the inner solid core |
| 07/02/2009 | CA2709909A1 Pharmaceutical composition |
| 07/02/2009 | CA2709538A1 Pharmaceutical formulations containing tolperisone |
| 07/02/2009 | CA2708875A1 Film-coated tablets containing drospirenone as active agent and a method for the preparation thereof |
| 07/02/2009 | CA2708869A1 Antibody formulation |
| 07/02/2009 | CA2706363A1 Method and compositions for cutaneous immunisation |
| 07/02/2009 | CA2706020A1 Allergen desensitization method |
| 07/01/2009 | EP2075254A1 Therapeutic use of a growth factor, NsG33 |
| 07/01/2009 | EP2075010A1 Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof |
| 07/01/2009 | EP2075009A1 Medicinal cooling emulsions |
| 07/01/2009 | EP2075000A1 Combination of azelastine and ciclesonide |
| 07/01/2009 | EP2074993A1 Venlafaxine-containing film-coated modified-release tablets |
| 07/01/2009 | EP2074992A1 Pharmaceutical formulations |
| 07/01/2009 | EP2074991A1 Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof |
| 07/01/2009 | EP2074990A1 Controlled release flurbiprofen and muscle relaxant combinations |
| 07/01/2009 | EP2074989A1 Abuse resistance opioid transdermal delivery device |
| 07/01/2009 | EP2074988A1 Sustained release composition and manufacturing method thereof |
| 07/01/2009 | EP2074987A1 Liposome composition of colistin for intravenous, oral, and cutaneous therapeutic use, and process for its preparation |
| 07/01/2009 | EP2073893A2 Electrically activated gel array for transdermal drug delivery |
| 07/01/2009 | EP2073848A2 Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
| 07/01/2009 | EP2073847A2 Methods and materials for reducing risk of cold and/or flu |
| 07/01/2009 | EP2073822A1 Processes for preparing fertilized egg components |
| 07/01/2009 | EP2073819A2 Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds |
| 07/01/2009 | EP2073800A2 Ophthalmic compositions comprising diglycine |
| 07/01/2009 | EP2073798A2 Pharmaceutical nimodipine compositions |
| 07/01/2009 | EP2073797A2 Pharmaceutical compositions |
| 07/01/2009 | EP2073796A1 Pharmaceutical formulation comprising metformin and repaglinide |
| 07/01/2009 | EP2073795A1 Abuse resistant drug formulation |
| 07/01/2009 | EP2073794A2 Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| 07/01/2009 | EP2073793A2 Compositions containing coenzyme q-10 in reduced form and dihydrolipoic acid |
| 07/01/2009 | EP2073792A2 Superporous hydrogels |
| 07/01/2009 | EP2073791A2 Capecitabine pediatric tablets |
| 07/01/2009 | EP2073790A1 Particle formation |
| 07/01/2009 | EP2073789A2 A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof |
| 07/01/2009 | EP2073783A2 Supramolecular co-colloids produced using macrocyclic polyanionic systems |
| 07/01/2009 | EP2073664A1 Skin care delivery device having a releasable backing |
| 07/01/2009 | EP2073643A2 Encapsulation of heat and moisture sensitive substances |
| 07/01/2009 | EP2073634A1 Stabilized prostaglandin e composition |
| 07/01/2009 | EP2037941A4 Cobalamin compositions and methods for treating or preventing mucositis |
| 07/01/2009 | EP2036574A4 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| 07/01/2009 | EP2007384B1 Orodispersible domperidone tablets |
| 07/01/2009 | EP2005948A9 Perfluorocarbon gas transferring emulsion for medico-biological use, the composition and the production method thereof a medicinal agent |
| 07/01/2009 | EP2005945A9 Oseltamivir phosphate granule and preparation mehtod thereof |
| 07/01/2009 | EP1830814B1 Taste masking system for non-plasticizing drugs |
| 07/01/2009 | EP1747006B1 Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug |
| 07/01/2009 | EP1729738B1 Polymeric compositions and dosage forms comprising the same |
| 07/01/2009 | EP1715739B1 Formulation of a synergistic insecticidal composition as a cyclodextrin-complex |
| 07/01/2009 | EP1713439B1 Pharmaceutical preparation for the oral cavity |
| 07/01/2009 | EP1651230B1 Medicaments for inhalation comprising steroids and a novel fluorene carboxylic acid ester |
| 07/01/2009 | EP1560563B1 Implantable medical device for controlled release of a substance |
| 07/01/2009 | EP1545470A4 Anti-microbial compositions and methods of using same |
| 07/01/2009 | EP1545457A4 Cell transport compositions and uses thereof |
| 07/01/2009 | EP1418864A4 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 07/01/2009 | EP1390004B1 Dental composition for treating hypersensitive teeth |
| 07/01/2009 | EP1381367A4 Aripiprazole oral solution |
| 07/01/2009 | EP1322316B1 Diuretic or sulphonylurea for use in antiviral treatment |
| 07/01/2009 | EP1263325B1 Embolic agents visible under ultrasound |
| 07/01/2009 | EP1019068B1 Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms |
| 07/01/2009 | CN101472570A Methods of using a thiazole derivative |
| 07/01/2009 | CN101472569A A pharmaceutical composition for the oral administration of omega polyenoic fatty acids |
| 07/01/2009 | CN101472568A Enteric coated particles containing an active ingredient |
| 07/01/2009 | CN101472567A Segmented pharmaceutical dosage forms |
| 07/01/2009 | CN101472566A Galenical formulations of aliskiren and hydrochlorothiazide |
| 07/01/2009 | CN101472564A High performance reticulated elastomeric matrix |
| 07/01/2009 | CN101472563A Method of separating vesicle, process for producing medicinal preparation, and method of evaluation |
| 07/01/2009 | CN101472562A Pharmaceutical compositions for vein irritating drugs |
| 07/01/2009 | CN101472561A Phenylphrine pulsed release formulations and pharmaceutical compositions |
| 07/01/2009 | CN101472560A Pharmaceutical composition for treating burns (variants) and a method for the production thereof (variants) |